CA
APGNW

CoreCap Advisors’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

CoreCap Advisors’s Portfolio APGNW Stock Details APGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1 Buy
+40
New +$3 ﹤0.01% 2399
2022
Q3 		– Sell
-40
Closed – – 2269
2022
Q2 		$0 Buy
+40
New +$7 ﹤0.01% 2331
2022
Q1 		– Sell
-40
Closed -$1K – 2265
2021
Q4 		$1K Buy
+40
New +$27 ﹤0.01% 2337

Other funds holding APGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

CoreCap Advisors's APGNW Position: Q4 2022 in Review

CoreCap Advisors opened a new position in Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q4 2022: 40 shares worth $1. The stake represents ﹤0.01% of the portfolio and ranks #2399 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in APGNW as recently as Q2 2022.

CoreCap Advisors first reported a position in APGNW in Q4 2021 and has held it in 3 quarters since. The position peaked at $1K in Q4 2021. 18 funds tracked by Wall St. Rank hold APGNW as of Q4 2022.

  • CoreCap Advisors held 40 shares of Apexigen, Inc. WarrantApexigen, Inc. Warrant worth $1 as of Q4 2022.
  • Apexigen, Inc. WarrantApexigen, Inc. Warrant was a new CoreCap Advisors position in Q4 2022.
  • Apexigen, Inc. WarrantApexigen, Inc. Warrant made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #2399 holding.
  • CoreCap Advisors first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q4 2021 and has held it in 3 quarters since.
  • CoreCap Advisors's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $1K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.